 |
NANCY M. HOLEKAMP, MD (CHAIR) Professor of Clinical Ophthalmology Washington University School of Medicine Director, Retina Services Pepose Vision Institute St Louis, Missouri |
 |
PRAVIN U. DUGEL, MD Managing Partner Retinal Consultants of Arizona Retinal Research Institute Phoenix, Arizona Clinical Professor Roski Eye Institute Keck School of Medicine University of Southern California Los Angeles, California |
 |
BARUCH D. KUPPERMANN, MD, PhD Roger F. Steinert Endowed Professor Chair, Department of Ophthalmology Director, Gavin Herbert Eye Institute University of California, Irvine Irvine, California |
 |
CARL D. REGILLO, MD Director, Retina Service Wills Eye Hospital Professor of Ophthalmology Thomas Jefferson University Philadelphia, Pennsylvania |
This educational activity is intended for retina specialists and other ophthalmologists who treat patients with neovascular age-related macular degeneration (nAMD).
LEARNING OBJECTIVES
Upon completion of this activity, participants will be better able to:
| • | Design strategies to identify nAMD as soon as possible after symptom onset |
| • | Discuss the molecular basis for differentiating current and emerging treatments for nAMD |
| • | Examine clinical trial data for approved and emerging treatments for nAMD |
| • | Develop individualized disease activity assessment and retreatment plans for patients with nAMD |
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of New York Eye and Ear Infirmary of Mount Sinai and MedEdicus LLC. The New York Eye and Ear Infirmary of Mount Sinai is accredited by the ACCME to provide continuing medical education for physicians.
New York Eye and Ear Infirmary of Mount Sinai designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing medical education activity is jointly provided by
New York Eye and Ear Infirmary of Mount Sinai and MedEdicus LLC.
This continuing medical education activity is supported through an
unrestricted educational grant from Novartis Pharmaceuticals Corporation.
| Distributed with: |  |
©2020 MedEdicus LLC. 199
MedEdicus LLC, 73 Redding Road, PO Box 839, Georgetown CT 06829
If you do not wish to receive email from MedEdicus in the future, please click here.